A distinct pattern of aberrant DNA methylation was mainly restricted to the distal promoter region of CEBPA (42.9%), whereas methylation of the CEBPA core promoter seems to be a rare event in AML (2.5%). The gene discussed is CEBPA; the disease is acute myeloid leukemia.